Cargando…
Therapies for Chronic Allograft Rejection
Remarkable advances have been made in the pathophysiology, diagnosis, and treatment of antibody-mediated rejection (ABMR) over the past decades, leading to improved graft outcomes. However, long-term failure is still high and effective treatment for chronic ABMR, an important cause of graft failure,...
Autores principales: | Kim, Min Young, Brennan, Daniel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082459/ https://www.ncbi.nlm.nih.gov/pubmed/33935762 http://dx.doi.org/10.3389/fphar.2021.651222 |
Ejemplares similares
-
Aspirin Attenuates Cardiac Allograft Rejection by Inhibiting the Maturation of Dendritic Cells via the NF-κB Signaling Pathway
por: Zhang, Xi, et al.
Publicado: (2021) -
Targeting PD-1/PD-L1 inhibits rejection in a heterotopic tracheal allograft model of lung transplantation
por: Kaiho, Taisuke, et al.
Publicado: (2023) -
Strategies for Local Gene Therapy of Corneal Allograft Rejection
por: Nguyen, Pho, et al.
Publicado: (2013) -
Immune Checkpoints Expression in Chronic Lung Allograft Rejection
por: Righi, Ilaria, et al.
Publicado: (2021) -
Molecular Profiling of Acute and Chronic Rejections of Renal Allografts
por: Petra, Hřibová, et al.
Publicado: (2013)